[RGLS] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
11-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -4.38%
YoY- -5.58%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 302 0 0 0 0 0 0 -
PBT -8,061 -7,824 -7,012 -7,139 -6,795 -7,551 -7,258 7.22%
Tax 100 -56 1 -45 1 -12 83 13.18%
NP -8,061 -7,824 -7,013 -7,094 -6,796 -7,539 -7,341 6.41%
Tax Rate - - - - - - - -
Total Cost 8,363 7,824 7,013 7,094 6,796 7,539 7,341 9.05%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -2,669.21 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.40 -0.40 -0.37 -0.42 -0.40 -0.50 -0.50 -13.78%
EPS Diluted -0.40 -0.40 -0.37 -0.42 -0.40 -0.50 -0.50 -13.78%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.